BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 22363634)

  • 21. Comparison of the immune response to recombinant gp120 in humans and chimpanzees.
    Berman PW; Eastman DJ; Wilkes DM; Nakamura GR; Gregory TJ; Schwartz D; Gorse G; Belshe R; Clements ML; Byrn RA
    AIDS; 1994 May; 8(5):591-601. PubMed ID: 7520248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma IgG to linear epitopes in the V2 and V3 regions of HIV-1 gp120 correlate with a reduced risk of infection in the RV144 vaccine efficacy trial.
    Gottardo R; Bailer RT; Korber BT; Gnanakaran S; Phillips J; Shen X; Tomaras GD; Turk E; Imholte G; Eckler L; Wenschuh H; Zerweck J; Greene K; Gao H; Berman PW; Francis D; Sinangil F; Lee C; Nitayaphan S; Rerks-Ngarm S; Kaewkungwal J; Pitisuttithum P; Tartaglia J; Robb ML; Michael NL; Kim JH; Zolla-Pazner S; Haynes BF; Mascola JR; Self S; Gilbert P; Montefiori DC
    PLoS One; 2013; 8(9):e75665. PubMed ID: 24086607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells.
    Heinkelein M; Sopper S; Jassoy C
    J Virol; 1995 Nov; 69(11):6925-31. PubMed ID: 7474110
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of New Regions in HIV-1 gp120 Variable 2 and 3 Loops that Bind to α4β7 Integrin Receptor.
    Peachman KK; Karasavvas N; Chenine AL; McLinden R; Rerks-Ngarm S; Jaranit K; Nitayaphan S; Pitisuttithum P; Tovanabutra S; Zolla-Pazner S; Michael NL; Kim JH; Alving CR; Rao M
    PLoS One; 2015; 10(12):e0143895. PubMed ID: 26625359
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum.
    Ferrari G; Pollara J; Kozink D; Harms T; Drinker M; Freel S; Moody MA; Alam SM; Tomaras GD; Ochsenbauer C; Kappes JC; Shaw GM; Hoxie JA; Robinson JE; Haynes BF
    J Virol; 2011 Jul; 85(14):7029-36. PubMed ID: 21543485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of T cell CD4 epitopes in HIV-infected individuals.
    Kunkl A; Valle MT; Fenoglio D; Dodi F; Morandi N; Rizzo F; Manca F
    Eur J Histochem; 1994; 38 Suppl 1():41-6. PubMed ID: 8547709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibody-dependent cellular cytotoxicity against primary HIV-infected CD4+ T cells is directly associated with the magnitude of surface IgG binding.
    Smalls-Mantey A; Doria-Rose N; Klein R; Patamawenu A; Migueles SA; Ko SY; Hallahan CW; Wong H; Liu B; You L; Scheid J; Kappes JC; Ochsenbauer C; Nabel GJ; Mascola JR; Connors M
    J Virol; 2012 Aug; 86(16):8672-80. PubMed ID: 22674985
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-F(ab')2 antibody in HIV type 1 infection: relationship to hypergammaglobulinemia and to antibody specific to the V3 loop region of glycoprotein 120.
    Morrison SA; Pearson SL; Steigbigel RT
    AIDS Res Hum Retroviruses; 1998 Apr; 14(6):491-8. PubMed ID: 9566551
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of HIV-1 infection on phenotypic and functional parameters of cellular immunity in chimpanzees.
    Ferrari G; Ottinger J; Place C; Nigida SM; Arthur LO; Weinhold KJ
    AIDS Res Hum Retroviruses; 1993 Jul; 9(7):647-56. PubMed ID: 8369169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on V3-specific cross-reactive T-cell responses in chimpanzees chronically infected with HIV-1IIIB.
    Nehete PN; Murthy KK; Satterfield WC; Arlinghaus RB; Sastry KJ
    AIDS; 1995 Jun; 9(6):567-72. PubMed ID: 7662194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human immunodeficiency virus type 1 glycoprotein 120-specific T lymphocytes provide intermolecular help for anti-CD4 autoantibody production in exposed uninfected subjects.
    Furci L; Beretta A; Siccardi A; Lazzarin A; Confetti C; Magnani Z; Scarpellini P; Lopalco L; Burastero SE
    AIDS Res Hum Retroviruses; 1997 Nov; 13(17):1461-9. PubMed ID: 9390745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immunodeficiency virus (HIV) type 1 strain MN neutralizing antibody in HIV-infected children: correlation with clinical status and prognostic value.
    Robert-Guroff M; Roilides E; Muldoon R; Venzon D; Husson R; Marshall D; Gallo RC; Pizzo PA
    J Infect Dis; 1993 Mar; 167(3):538-46. PubMed ID: 7680059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural definition of an antibody-dependent cellular cytotoxicity response implicated in reduced risk for HIV-1 infection.
    Acharya P; Tolbert WD; Gohain N; Wu X; Yu L; Liu T; Huang W; Huang CC; Kwon YD; Louder RK; Luongo TS; McLellan JS; Pancera M; Yang Y; Zhang B; Flinko R; Foulke JS; Sajadi MM; Kamin-Lewis R; Robinson JE; Martin L; Kwong PD; Guan Y; DeVico AL; Lewis GK; Pazgier M
    J Virol; 2014 Nov; 88(21):12895-906. PubMed ID: 25165110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimpanzee CD4+ T cells are relatively insensitive to HIV-1 envelope-mediated inhibition of CD154 up-regulation.
    Rutjens E; Vermeulen J; Verstrepen B; Hofman S; Prins JM; Srivastava I; Heeney JL; Koopman G
    Eur J Immunol; 2008 Apr; 38(4):1164-72. PubMed ID: 18383039
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4 epitope masking by gp120/anti-gp120 antibody complexes. A potential mechanism for CD4+ cell function down-regulation in AIDS patients.
    Amadori A; De Silvestro G; Zamarchi R; Veronese ML; Mazza MR; Schiavo G; Panozzo M; De Rossi A; Ometto L; Mous J
    J Immunol; 1992 May; 148(9):2709-16. PubMed ID: 1374095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the immune responses in chimpanzees infected with HIV type 1 isolates.
    Juompan LY; Hutchinson K; Montefiori DC; Nidtha S; Villinger F; Novembre FJ
    AIDS Res Hum Retroviruses; 2008 Apr; 24(4):573-86. PubMed ID: 18426337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Broad-spectrum inhibition of HIV-1 by a monoclonal antibody directed against a gp120-induced epitope of CD4.
    Burastero SE; Frigerio B; Lopalco L; Sironi F; Breda D; Longhi R; Scarlatti G; Canevari S; Figini M; Lusso P
    PLoS One; 2011; 6(7):e22081. PubMed ID: 21818294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Propagation of CD4+ T cells specific for HIV type 1 envelope gp120 from chronically HIV type 1-infected subjects.
    Cohen S; Tuen M; Hioe CE
    AIDS Res Hum Retroviruses; 2003 Sep; 19(9):793-806. PubMed ID: 14585210
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-covalent complexes of HIV gp120 with CD4 and/or mAbs enhance activation of gp120-specific T clones and provide intermolecular help for anti-CD4 antibody production.
    Manca F; Seravalli E; Valle MT; Fenoglio D; Kunkl A; Li Pira G; Zolla-Pazner S; Celada F
    Int Immunol; 1993 Sep; 5(9):1109-17. PubMed ID: 7902128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CD4+ lymphocyte depletion in HIV-infected patients is associated with gp120-immunoglobulin-complement attachment to CD4+ cells.
    Daniel V; Süsal C; Prodeus AP; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Vox Sang; 1993; 64(1):31-6. PubMed ID: 8095360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.